IMC-Chicago, LLC - BIOMARIN PHARMACEUTICAL INC ownership

BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061G951. A total of 5 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
IMC-Chicago, LLC ownership history of BIOMARIN PHARMACEUTICAL INC
ValueSharesWeighting
Q2 2023$875,468
-40.4%
10,100
-28.9%
0.00%
-50.0%
Q4 2022$1,469,558
-3.7%
14,200
-21.1%
0.00%0.0%
Q3 2022$1,526,000
-50.4%
18,000
-48.3%
0.00%
-33.3%
Q4 2021$3,075,000
-25.1%
34,800
-29.3%
0.00%
-40.0%
Q2 2021$4,105,000
-15.1%
49,200
-23.1%
0.01%
-28.6%
Q1 2021$4,833,000
+45.8%
64,000
+69.3%
0.01%
+75.0%
Q4 2020$3,315,000
+347.4%
37,800
+334.5%
0.00%
+100.0%
Q4 2018$741,0008,7000.00%
Other shareholders
BIOMARIN PHARMACEUTICAL INC shareholders Q3 2021
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 146,800$12,161,0000.12%
Hudson Bay Capital Management LP 50,000$4,142,0000.04%
SIMPLEX TRADING, LLC 404$225,0000.01%
Timber Hill LLC 12,100$1,002,0000.01%
JPMORGAN CHASE & CO 40,000$3,314,0000.00%
SG Americas Securities, LLC 14,000$130,0000.00%
View complete list of BIOMARIN PHARMACEUTICAL INC shareholders